Physician

Irene Anna Barbazetto, MD

According to 2025 Medicare claims, Irene Barbazetto, MD (NPI: 1881894566) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (NPI: 1598700791; TIN: 132721177) and primary practice location at 10604-2922. Barbazetto is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Barbazetto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 912 traditional Medicare patients, billed 38,467 HCPCS/CPT codes, and received $3,170,857 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 599 prescription claims across 217 beneficiaries totaling $108,592 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 46 records totaling $55,010. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,406,707 to $3,170,857. Similarly, Part D prescription costs have moved sharply higher in recent years, from $89,031 to $108,592. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2015 Medicare payment: $1,406,707 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,736,895 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,829,712 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,005,929 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,118,547 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,960,290 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,302,846 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,686,100 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,288,586 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,170,857 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154478,010$1,406,707
201651410,273$1,736,895
201753110,021$1,829,712
201857212,247$2,005,929
201958713,311$2,118,547
202053710,699$1,960,290
202161111,558$2,302,846
202267114,653$2,686,100
202384525,915$3,288,586
202491238,467$3,170,857

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$55K$111K2015 Drug cost: $89,031 (USD; Tot_Drug_Cst)2016 Drug cost: $96,464 (USD; Tot_Drug_Cst)2017 Drug cost: $56,156 (USD; Tot_Drug_Cst)2018 Drug cost: $24,966 (USD; Tot_Drug_Cst)2019 Drug cost: $39,319 (USD; Tot_Drug_Cst)2020 Drug cost: $62,734 (USD; Tot_Drug_Cst)2021 Drug cost: $53,336 (USD; Tot_Drug_Cst)2022 Drug cost: $99,814 (USD; Tot_Drug_Cst)2023 Drug cost: $110,889 (USD; Tot_Drug_Cst)2024 Drug cost: $108,592 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015135413$89,031
2016213631$96,464
201794244$56,156
201869219$24,966
201995296$39,319
202095280$62,734
202198265$53,336
2022172484$99,814
2023214589$110,889
2024217599$108,592

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2851,508$122
92014Established patient complete exam of visual system399451$118
92012Established patient problem focused exam of visual system5912,209$83
92134Imaging of retina8892,737$38
92250Photography of the retina710819$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine291,620$33,429
XiidraLifitegrast20974$17,616
ProlensaBromfenac Sodium21863$6,914
Bromfenac SodiumBromfenac Sodium401,296$5,926
Prednisolone AcetatePrednisolone Acetate542,482$3,032

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$788Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.15$54,222Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Irene Anna Barbazetto, MD?

Tedicare shows public-source Medicare data for Irene Anna Barbazetto, MD (NPI 1881894566), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Irene Anna Barbazetto, MD have ACO affiliation data?

Irene Anna Barbazetto, MD is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to Irene Anna Barbazetto, MD?

Irene Anna Barbazetto, MD is linked to VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (billing NPI 1598700791) in the available physician profile data.

Does Irene Anna Barbazetto, MD have Open Payments data?

Irene Anna Barbazetto, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.